Development of tumor lysis syndrome (TLS): A potential risk factor in cancer patients receiving anticancer therapy.

Bioinformation · 2014 · PMC4261116 · PMID 25512688

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The mean values of AST in case of control group is 24.06 ± 6.02, where as in case of patients of TLS it is 56.90 ± 17.34 IU/L which shows that AST is highly significant in case of patients suffering from TLS.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.